Nifty
Sensex
:
:
24868.60
81101.32
95.45 (0.39%)
314.02 (0.39%)

Pharmaceuticals & Drugs - API

Rating :
61/99

BSE: 524164 | NSE: IOLCP

117.86
09-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  113.39
  •  121.55
  •  113
  •  111.79
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  65624027
  •  7734098897.43
  •  121.55
  •  57.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,469.79
  • 33.04
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,378.68
  • 0.68%
  • 2.02

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.62%
  • 11.18%
  • 30.22%
  • FII
  • DII
  • Others
  • 2.59%
  • 0.02%
  • 3.37%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.61
  • 1.12
  • -2.12

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.68
  • -19.33
  • -2.16

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -25.65
  • -10.11

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.69
  • 17.69
  • 17.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.48
  • 1.48
  • 1.48

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.09
  • 9.09
  • 9.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
551.69
502.38
9.82%
527.78
503.92
4.73%
523.30
520.39
0.56%
525.75
545.30
-3.59%
Expenses
489.55
451.27
8.48%
465.03
454.40
2.34%
476.43
476.04
0.08%
484.18
481.10
0.64%
EBITDA
62.14
51.11
21.58%
62.75
49.52
26.72%
46.87
44.35
5.68%
41.57
64.20
-35.25%
EBIDTM
11.26%
10.17%
11.89%
9.83%
8.96%
8.52%
7.91%
11.77%
Other Income
7.37
7.38
-0.14%
4.53
7.52
-39.76%
4.07
8.38
-51.43%
6.43
7.11
-9.56%
Interest
4.23
2.15
96.74%
4.03
3.41
18.18%
4.46
4.30
3.72%
4.12
4.44
-7.21%
Depreciation
19.77
16.82
17.54%
18.55
16.43
12.90%
18.68
16.34
14.32%
17.94
15.69
14.34%
PBT
45.51
39.52
15.16%
44.70
37.20
20.16%
27.80
32.09
-13.37%
25.94
51.18
-49.32%
Tax
11.58
9.55
21.26%
13.28
9.58
38.62%
7.27
9.01
-19.31%
6.79
13.31
-48.99%
PAT
33.93
29.97
13.21%
31.42
27.62
13.76%
20.53
23.08
-11.05%
19.15
37.87
-49.43%
PATM
6.15%
5.97%
5.95%
5.48%
3.92%
4.44%
3.64%
6.94%
EPS
1.16
1.02
13.73%
1.07
0.94
13.83%
0.70
0.79
-11.39%
0.65
1.29
-49.61%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Net Sales
2,128.52
2,079.21
2,132.79
2,217.11
2,184.02
Net Sales Growth
2.73%
-2.51%
-3.80%
1.52%
 
Cost Of Goods Sold
1,419.71
1,391.85
1,396.95
1,547.09
1,570.51
Gross Profit
708.81
687.36
735.84
670.02
613.51
GP Margin
33.30%
33.06%
34.50%
30.22%
28.09%
Total Expenditure
1,915.19
1,876.91
1,902.20
1,991.44
1,925.73
Power & Fuel Cost
-
114.93
149.05
131.98
78.18
% Of Sales
-
5.53%
6.99%
5.95%
3.58%
Employee Cost
-
216.57
201.02
168.21
141.30
% Of Sales
-
10.42%
9.43%
7.59%
6.47%
Manufacturing Exp.
-
47.39
47.67
43.07
36.86
% Of Sales
-
2.28%
2.24%
1.94%
1.69%
General & Admin Exp.
-
8.10
9.01
6.54
5.12
% Of Sales
-
0.39%
0.42%
0.29%
0.23%
Selling & Distn. Exp.
-
62.21
51.25
61.85
66.84
% Of Sales
-
2.99%
2.40%
2.79%
3.06%
Miscellaneous Exp.
-
35.86
47.25
32.70
26.92
% Of Sales
-
1.72%
2.22%
1.47%
1.23%
EBITDA
213.33
202.30
230.59
225.67
258.29
EBITDA Margin
10.02%
9.73%
10.81%
10.18%
11.83%
Other Income
22.40
22.41
30.07
25.61
32.04
Interest
16.84
14.76
16.10
16.47
8.29
Depreciation
74.94
71.99
62.91
46.16
43.26
PBT
143.95
137.96
181.65
188.65
238.78
Tax
38.92
36.89
47.22
49.51
57.18
Tax Rate
27.04%
26.74%
26.00%
26.24%
25.43%
PAT
105.03
101.07
134.43
139.14
167.67
PAT before Minority Interest
105.03
101.07
134.43
139.14
167.67
Minority Interest
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.93%
4.86%
6.30%
6.28%
7.68%
PAT Growth
-11.40%
-24.82%
-3.39%
-17.02%
 
EPS
3.58
3.44
4.58
4.74
5.71

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Shareholder's Funds
1,687.66
1,611.51
1,507.72
1,392.28
Share Capital
58.71
58.71
58.71
58.71
Total Reserves
1,628.95
1,552.80
1,449.01
1,333.57
Non-Current Liabilities
84.50
72.89
58.15
56.62
Secured Loans
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
6.69
6.71
1.65
3.01
Current Liabilities
638.58
597.10
502.52
575.29
Trade Payables
427.56
469.18
314.22
409.29
Other Current Liabilities
63.34
54.67
54.28
54.02
Short Term Borrowings
117.04
32.76
79.63
42.75
Short Term Provisions
30.64
40.49
54.39
69.23
Total Liabilities
2,410.74
2,281.50
2,068.39
2,024.19
Net Block
1,170.71
933.13
751.81
560.64
Gross Block
1,544.27
1,235.97
995.24
761.99
Accumulated Depreciation
373.56
302.84
243.43
201.35
Non Current Assets
1,230.73
1,124.63
1,101.74
881.48
Capital Work in Progress
21.93
100.87
89.64
105.20
Non Current Investment
17.41
17.41
17.41
0.00
Long Term Loans & Adv.
12.15
23.62
9.52
10.77
Other Non Current Assets
8.53
49.60
233.36
204.87
Current Assets
1,180.01
1,156.87
966.65
1,142.71
Current Investments
3.30
2.88
2.56
2.37
Inventories
360.62
424.84
325.52
409.89
Sundry Debtors
513.69
471.23
505.28
469.80
Cash & Bank
208.15
142.89
21.83
139.99
Other Current Assets
94.25
24.91
29.86
30.99
Short Term Loans & Adv.
67.33
90.12
81.60
89.67
Net Current Assets
541.43
559.77
464.13
567.42
Total Assets
2,410.74
2,281.50
2,068.39
2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
178.62
289.78
122.27
93.05
PBT
137.96
181.65
188.65
224.85
Adjustment
79.85
59.82
44.41
33.12
Changes in Working Capital
-20.87
90.33
-63.69
-102.34
Cash after chg. in Working capital
196.94
331.80
169.37
155.63
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-18.32
-42.02
-47.10
-62.58
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-154.18
-190.98
-120.00
-120.52
Net Fixed Assets
-229.36
-251.96
-217.16
Net Investments
-0.42
-0.32
-17.80
Others
75.60
61.30
114.96
Cash from Financing Activity
46.04
-92.50
-4.11
-1.64
Net Cash Inflow / Outflow
70.48
6.30
-1.84
-29.11
Opening Cash & Equivalents
7.69
1.39
3.23
32.34
Closing Cash & Equivalent
78.17
7.69
1.39
3.23

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
57.49
54.90
256.81
237.15
ROA
4.31%
6.18%
6.80%
8.28%
ROE
6.13%
8.62%
9.60%
12.04%
ROCE
8.86%
12.24%
13.57%
16.25%
Fixed Asset Turnover
1.50
1.91
2.52
2.87
Receivable days
86.45
83.56
80.26
78.51
Inventory Days
68.94
64.21
60.53
68.50
Payable days
117.58
102.34
85.35
95.12
Cash Conversion Cycle
37.81
45.42
55.45
51.89
Total Debt/Equity
0.07
0.02
0.05
0.03
Interest Cover
10.35
12.28
12.45
28.12

News Update:


  • IOL Chem & Pharma - Quarterly Results
    7th Aug 2025, 14:30 PM

    Read More
  • IOL Chemicals registers Acetic Anhydride with REACH
    16th Jun 2025, 12:30 PM

    This certification allows the company to export the product across all the countries in the European Union

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.